These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 38052232

  • 1. LncRNA H19 Influences Cellular Activities via the miR-454-3p/BHLHE40 Axis in Anaplastic Thyroid Carcinoma.
    Wu Y, Yang J, Zhang H, Cheng J, Lei P, Huang J.
    Horm Metab Res; 2024 May; 56(5):392-399. PubMed ID: 38052232
    [Abstract] [Full Text] [Related]

  • 2. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis.
    Zhang H, Yu Y, Zhang K, Liu X, Dai Y, Jiao X.
    Bioengineered; 2019 Dec; 10(1):306-315. PubMed ID: 31299871
    [Abstract] [Full Text] [Related]

  • 3. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J, Zhao D, Meng Q.
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [Abstract] [Full Text] [Related]

  • 4. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L, Zou H, Li B.
    Cancer Biol Ther; 2019 Aug; 20(11):1355-1365. PubMed ID: 31500506
    [Abstract] [Full Text] [Related]

  • 5. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
    Zhong Y, Yu F, Yang L, Wang Y, Liu L, Jia C, Cai H, Yang J, Sheng S, Lv Z, Weng L, Wu B, Zhang X.
    J Transl Med; 2023 Nov 16; 21(1):817. PubMed ID: 37974228
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Zhang X, Liu L, Deng X, Li D, Cai H, Ma Y, Jia C, Wu B, Fan Y, Lv Z.
    Oncogene; 2019 Jan 16; 38(5):699-715. PubMed ID: 30171257
    [Abstract] [Full Text] [Related]

  • 7. miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9.
    Zhang Y, Li K, Wang W, Han J.
    Int J Exp Pathol; 2021 Aug 16; 102(4-5):209-217. PubMed ID: 34719830
    [Abstract] [Full Text] [Related]

  • 8. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D, Xing N, Yang T, Liu J, Zhao H, He J, Ai Y, Yang J.
    Cancer Med; 2020 Oct 16; 9(19):7218-7230. PubMed ID: 32767662
    [Abstract] [Full Text] [Related]

  • 9. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H, Haghpanah V, Irani S, Arefian E, Sohi AN, Fallah P, Soleimani M.
    Daru; 2019 Jun 16; 27(1):1-7. PubMed ID: 31077090
    [Abstract] [Full Text] [Related]

  • 10. LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling.
    Ding D, Li C, Zhao T, Li D, Yang L, Zhang B.
    Mol Cells; 2018 May 31; 41(5):423-435. PubMed ID: 29754471
    [Abstract] [Full Text] [Related]

  • 11. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
    Yan P, Su Z, Zhang Z, Gao T.
    Int J Oncol; 2019 Nov 31; 55(5):988-1002. PubMed ID: 31485599
    [Abstract] [Full Text] [Related]

  • 12. LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway.
    Ning M, Qin S, Tian J, Wang Y, Liu Q.
    Bioengineered; 2021 Dec 31; 12(1):1543-1554. PubMed ID: 33999777
    [Abstract] [Full Text] [Related]

  • 13. C5AR1-induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer.
    Liu B, Sun Y, Geng T, Wang H, Wu Z, Xu L, Zhang M, Niu X, Zhao C, Shang J, Shang F.
    Mol Carcinog; 2024 Oct 31; 63(10):1938-1952. PubMed ID: 38934768
    [Abstract] [Full Text] [Related]

  • 14. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
    Bu Q, You F, Pan G, Yuan Q, Cui T, Hao L, Zhang J.
    Biomed Pharmacother; 2017 Apr 31; 88():443-448. PubMed ID: 28122310
    [Abstract] [Full Text] [Related]

  • 15. LncRNA H19 Promotes Gastric Cancer Metastasis via miR-148-3p/SOX-12 Axis.
    Zhang X, Wang G, Li X, Liu Y, Wu X, Zhou Y, Liu J, Wang H, Jiao R, Chen Y, Wang Q.
    Anal Cell Pathol (Amst); 2024 Apr 31; 2024():6217134. PubMed ID: 39184399
    [Abstract] [Full Text] [Related]

  • 16. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis.
    Du YL, Liang Y, Cao Y, Liu L, Li J, Shi GQ.
    Biochem Genet; 2021 Apr 31; 59(2):437-452. PubMed ID: 33057875
    [Abstract] [Full Text] [Related]

  • 17. LncRNA H19 Regulates Lipopolysaccharide (LPS)-Induced Apoptosis and Inflammation of BV2 Microglia Cells Through Targeting miR-325-3p/NEUROD4 Axis.
    Gu E, Pan W, Chen K, Zheng Z, Chen G, Cai P.
    J Mol Neurosci; 2021 Jun 31; 71(6):1256-1265. PubMed ID: 33205379
    [Abstract] [Full Text] [Related]

  • 18. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.
    Zhang W, Ji W, Zhao X.
    BMC Cancer; 2019 Nov 12; 19(1):1093. PubMed ID: 31718618
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long non-coding RNA LINC00488 facilitates thyroid cancer cell progression through miR-376a-3p/PON2.
    Xie F, Li L, Luo Y, Chen R, Mei J.
    Biosci Rep; 2021 Mar 26; 41(3):. PubMed ID: 33600548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.